Biotts logo

Biotts

Proprietary drugs in oncology, diabetology, and pain utilizing unique formulations and drug delivery technologies

21 employees · est. 2018 · Poland

VS
Zosano Pharma logo

Zosano Pharma

Live at the Speed of Life

48 employees · est. 2006 · Fremont, United States

Zosano Pharma is the older company (2018 vs 2006).

Side-by-Side Comparison

Biotts Zosano Pharma
Founded
2018 2006 older
Headquarters
Poland Fremont, United States
Employees
21 48
Industry
Biotechnology Biopharma, Biotechnology
Funding Stage
Non Equity Assistance Post Ipo Debt
Total Funding
$1.50M $271.92M
Funding Rounds
2 14
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biotech Company, Proprietary Drugs, Oncology, Diabetology, Pain Management, Drug Delivery Technologies, Transdermal Drug Delivery, Pharmaceutical Industry, Bioavailability, Targeted Therapy, Multifunctional Transdermal Carrier, Transdermal Therapeutic System, Drug Formulation, Technical Development Collaborations Zosano Pharma, CNS Company, Transdermal Drug Delivery, Rapid Symptom Relief, Novel Formulations, Existing Drugs, Skin Administration, Therapeutic Advantages, Patient Populations, Drug Delivery System, Transdermal System, Room-temperature Stability, Unmet Needs, Proprietory Technology
Website
biotts.com zosanopharma.com
Biotts logo

About Biotts

Biotts, a pioneering Polish-American biotech company, is focused on developing proprietary drugs in oncology, diabetology, and pain by leveraging unique formulations and drug delivery technologies. The company has made significant strides in the field with the breakthrough technology of its universa...

Zosano Pharma logo

About Zosano Pharma

Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy profiles, but altering their delivery profile using the Company’s proprietary transdermal system. The Company’s goal is to make transder...

We will tell you when either one moves

BounceWatch watches Biotts and Zosano Pharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Biotts and Zosano Pharma — by email.

Frequently Asked Questions

Biotts — Proprietary drugs in oncology, diabetology, and pain utilizing unique formulations and drug delivery technologies. Zosano Pharma — Live at the Speed of Life. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Biotts has raised $1.50M while Zosano Pharma has raised $271.92M.
Biotts and Zosano Pharma operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Biotts with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Biotts on 12 Sep 2024, and Zosano Pharma on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes